Global Human Rabies Vaccine (Vero Cell) Supply, Demand and Key Producers, 2023-2029
The global Human Rabies Vaccine (Vero Cell) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report studies the global Human Rabies Vaccine (Vero Cell) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Rabies Vaccine (Vero Cell), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Rabies Vaccine (Vero Cell) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Rabies Vaccine (Vero Cell) total production and demand, 2018-2029, (K Units)
Global Human Rabies Vaccine (Vero Cell) total production value, 2018-2029, (USD Million)
Global Human Rabies Vaccine (Vero Cell) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Rabies Vaccine (Vero Cell) domestic production, consumption, key domestic manufacturers and share
Global Human Rabies Vaccine (Vero Cell) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Rabies Vaccine (Vero Cell) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Liaoning Chengda, Guangzhou Nuocheng, Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt. and Chengdu Kanghua Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Rabies Vaccine (Vero Cell) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Rabies Vaccine (Vero Cell) Market, By Region:
1. How big is the global Human Rabies Vaccine (Vero Cell) market?
2. What is the demand of the global Human Rabies Vaccine (Vero Cell) market?
3. What is the year over year growth of the global Human Rabies Vaccine (Vero Cell) market?
4. What is the production and production value of the global Human Rabies Vaccine (Vero Cell) market?
5. Who are the key producers in the global Human Rabies Vaccine (Vero Cell) market?
6. What are the growth factors driving the market demand?
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report studies the global Human Rabies Vaccine (Vero Cell) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Rabies Vaccine (Vero Cell), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Rabies Vaccine (Vero Cell) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Rabies Vaccine (Vero Cell) total production and demand, 2018-2029, (K Units)
Global Human Rabies Vaccine (Vero Cell) total production value, 2018-2029, (USD Million)
Global Human Rabies Vaccine (Vero Cell) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Rabies Vaccine (Vero Cell) domestic production, consumption, key domestic manufacturers and share
Global Human Rabies Vaccine (Vero Cell) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Rabies Vaccine (Vero Cell) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Rabies Vaccine (Vero Cell) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Liaoning Chengda, Guangzhou Nuocheng, Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt. and Chengdu Kanghua Biology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Rabies Vaccine (Vero Cell) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Rabies Vaccine (Vero Cell) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 0.5ml
- 1ml
- Hospital
- Clinic
- Liaoning Chengda
- Guangzhou Nuocheng
- Ningbo Rong'an
- Hualan Bio-vaccine
- Sanofi Pasteur SA
- Bharat Biotech
- Bavarian Nordic
- Serum Institute of India Pvt.
- Chengdu Kanghua Biology
- Changchun Zhuoyi Biology
- Dalian Yali Peak
- Jilin Huikang Biopharmaceutical Co., Ltd.
1. How big is the global Human Rabies Vaccine (Vero Cell) market?
2. What is the demand of the global Human Rabies Vaccine (Vero Cell) market?
3. What is the year over year growth of the global Human Rabies Vaccine (Vero Cell) market?
4. What is the production and production value of the global Human Rabies Vaccine (Vero Cell) market?
5. Who are the key producers in the global Human Rabies Vaccine (Vero Cell) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Rabies Vaccine (Vero Cell) Introduction
1.2 World Human Rabies Vaccine (Vero Cell) Supply & Forecast
1.2.1 World Human Rabies Vaccine (Vero Cell) Production Value (2018 & 2022 & 2029)
1.2.2 World Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.2.3 World Human Rabies Vaccine (Vero Cell) Pricing Trends (2018-2029)
1.3 World Human Rabies Vaccine (Vero Cell) Production by Region (Based on Production Site)
1.3.1 World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018-2029)
1.3.2 World Human Rabies Vaccine (Vero Cell) Production by Region (2018-2029)
1.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2029)
1.3.4 North America Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.5 Europe Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.6 China Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.7 Japan Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Rabies Vaccine (Vero Cell) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Rabies Vaccine (Vero Cell) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Rabies Vaccine (Vero Cell) Demand (2018-2029)
2.2 World Human Rabies Vaccine (Vero Cell) Consumption by Region
2.2.1 World Human Rabies Vaccine (Vero Cell) Consumption by Region (2018-2023)
2.2.2 World Human Rabies Vaccine (Vero Cell) Consumption Forecast by Region (2024-2029)
2.3 United States Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.4 China Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.5 Europe Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.6 Japan Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.7 South Korea Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.8 ASEAN Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.9 India Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
3 WORLD HUMAN RABIES VACCINE (VERO CELL) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Rabies Vaccine (Vero Cell) Production Value by Manufacturer (2018-2023)
3.2 World Human Rabies Vaccine (Vero Cell) Production by Manufacturer (2018-2023)
3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023)
3.4 Human Rabies Vaccine (Vero Cell) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Rabies Vaccine (Vero Cell) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Rabies Vaccine (Vero Cell) in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Rabies Vaccine (Vero Cell) in 2022
3.6 Human Rabies Vaccine (Vero Cell) Market: Overall Company Footprint Analysis
3.6.1 Human Rabies Vaccine (Vero Cell) Market: Region Footprint
3.6.2 Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
3.6.3 Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Comparison
4.1.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Comparison
4.2.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Comparison
4.3.1 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
4.5 China Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share
4.5.1 China Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
4.6 Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Rabies Vaccine (Vero Cell) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.5ml
5.2.2 1ml
5.3 Market Segment by Type
5.3.1 World Human Rabies Vaccine (Vero Cell) Production by Type (2018-2029)
5.3.2 World Human Rabies Vaccine (Vero Cell) Production Value by Type (2018-2029)
5.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Rabies Vaccine (Vero Cell) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Human Rabies Vaccine (Vero Cell) Production by Application (2018-2029)
6.3.2 World Human Rabies Vaccine (Vero Cell) Production Value by Application (2018-2029)
6.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Liaoning Chengda
7.1.1 Liaoning Chengda Details
7.1.2 Liaoning Chengda Major Business
7.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
7.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Liaoning Chengda Recent Developments/Updates
7.1.6 Liaoning Chengda Competitive Strengths & Weaknesses
7.2 Guangzhou Nuocheng
7.2.1 Guangzhou Nuocheng Details
7.2.2 Guangzhou Nuocheng Major Business
7.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
7.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Guangzhou Nuocheng Recent Developments/Updates
7.2.6 Guangzhou Nuocheng Competitive Strengths & Weaknesses
7.3 Ningbo Rong'an
7.3.1 Ningbo Rong'an Details
7.3.2 Ningbo Rong'an Major Business
7.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
7.3.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Ningbo Rong'an Recent Developments/Updates
7.3.6 Ningbo Rong'an Competitive Strengths & Weaknesses
7.4 Hualan Bio-vaccine
7.4.1 Hualan Bio-vaccine Details
7.4.2 Hualan Bio-vaccine Major Business
7.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
7.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hualan Bio-vaccine Recent Developments/Updates
7.4.6 Hualan Bio-vaccine Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur SA
7.5.1 Sanofi Pasteur SA Details
7.5.2 Sanofi Pasteur SA Major Business
7.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
7.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur SA Recent Developments/Updates
7.5.6 Sanofi Pasteur SA Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
7.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Details
7.7.2 Bavarian Nordic Major Business
7.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
7.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bavarian Nordic Recent Developments/Updates
7.7.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.8 Serum Institute of India Pvt.
7.8.1 Serum Institute of India Pvt. Details
7.8.2 Serum Institute of India Pvt. Major Business
7.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
7.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Serum Institute of India Pvt. Recent Developments/Updates
7.8.6 Serum Institute of India Pvt. Competitive Strengths & Weaknesses
7.9 Chengdu Kanghua Biology
7.9.1 Chengdu Kanghua Biology Details
7.9.2 Chengdu Kanghua Biology Major Business
7.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
7.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Chengdu Kanghua Biology Recent Developments/Updates
7.9.6 Chengdu Kanghua Biology Competitive Strengths & Weaknesses
7.10 Changchun Zhuoyi Biology
7.10.1 Changchun Zhuoyi Biology Details
7.10.2 Changchun Zhuoyi Biology Major Business
7.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
7.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Changchun Zhuoyi Biology Recent Developments/Updates
7.10.6 Changchun Zhuoyi Biology Competitive Strengths & Weaknesses
7.11 Dalian Yali Peak
7.11.1 Dalian Yali Peak Details
7.11.2 Dalian Yali Peak Major Business
7.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
7.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Dalian Yali Peak Recent Developments/Updates
7.11.6 Dalian Yali Peak Competitive Strengths & Weaknesses
7.12 Jilin Huikang Biopharmaceutical Co., Ltd.
7.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Details
7.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
7.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
7.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.12.6 Jilin Huikang Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Rabies Vaccine (Vero Cell) Industry Chain
8.2 Human Rabies Vaccine (Vero Cell) Upstream Analysis
8.2.1 Human Rabies Vaccine (Vero Cell) Core Raw Materials
8.2.2 Main Manufacturers of Human Rabies Vaccine (Vero Cell) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Rabies Vaccine (Vero Cell) Production Mode
8.6 Human Rabies Vaccine (Vero Cell) Procurement Model
8.7 Human Rabies Vaccine (Vero Cell) Industry Sales Model and Sales Channels
8.7.1 Human Rabies Vaccine (Vero Cell) Sales Model
8.7.2 Human Rabies Vaccine (Vero Cell) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Rabies Vaccine (Vero Cell) Introduction
1.2 World Human Rabies Vaccine (Vero Cell) Supply & Forecast
1.2.1 World Human Rabies Vaccine (Vero Cell) Production Value (2018 & 2022 & 2029)
1.2.2 World Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.2.3 World Human Rabies Vaccine (Vero Cell) Pricing Trends (2018-2029)
1.3 World Human Rabies Vaccine (Vero Cell) Production by Region (Based on Production Site)
1.3.1 World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018-2029)
1.3.2 World Human Rabies Vaccine (Vero Cell) Production by Region (2018-2029)
1.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2029)
1.3.4 North America Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.5 Europe Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.6 China Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.3.7 Japan Human Rabies Vaccine (Vero Cell) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Rabies Vaccine (Vero Cell) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Rabies Vaccine (Vero Cell) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Rabies Vaccine (Vero Cell) Demand (2018-2029)
2.2 World Human Rabies Vaccine (Vero Cell) Consumption by Region
2.2.1 World Human Rabies Vaccine (Vero Cell) Consumption by Region (2018-2023)
2.2.2 World Human Rabies Vaccine (Vero Cell) Consumption Forecast by Region (2024-2029)
2.3 United States Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.4 China Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.5 Europe Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.6 Japan Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.7 South Korea Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.8 ASEAN Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
2.9 India Human Rabies Vaccine (Vero Cell) Consumption (2018-2029)
3 WORLD HUMAN RABIES VACCINE (VERO CELL) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Rabies Vaccine (Vero Cell) Production Value by Manufacturer (2018-2023)
3.2 World Human Rabies Vaccine (Vero Cell) Production by Manufacturer (2018-2023)
3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023)
3.4 Human Rabies Vaccine (Vero Cell) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Rabies Vaccine (Vero Cell) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Rabies Vaccine (Vero Cell) in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Rabies Vaccine (Vero Cell) in 2022
3.6 Human Rabies Vaccine (Vero Cell) Market: Overall Company Footprint Analysis
3.6.1 Human Rabies Vaccine (Vero Cell) Market: Region Footprint
3.6.2 Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
3.6.3 Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Comparison
4.1.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Comparison
4.2.1 United States VS China: Human Rabies Vaccine (Vero Cell) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Rabies Vaccine (Vero Cell) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Comparison
4.3.1 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
4.5 China Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share
4.5.1 China Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
4.6 Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Rabies Vaccine (Vero Cell) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 0.5ml
5.2.2 1ml
5.3 Market Segment by Type
5.3.1 World Human Rabies Vaccine (Vero Cell) Production by Type (2018-2029)
5.3.2 World Human Rabies Vaccine (Vero Cell) Production Value by Type (2018-2029)
5.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Rabies Vaccine (Vero Cell) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Human Rabies Vaccine (Vero Cell) Production by Application (2018-2029)
6.3.2 World Human Rabies Vaccine (Vero Cell) Production Value by Application (2018-2029)
6.3.3 World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Liaoning Chengda
7.1.1 Liaoning Chengda Details
7.1.2 Liaoning Chengda Major Business
7.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
7.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Liaoning Chengda Recent Developments/Updates
7.1.6 Liaoning Chengda Competitive Strengths & Weaknesses
7.2 Guangzhou Nuocheng
7.2.1 Guangzhou Nuocheng Details
7.2.2 Guangzhou Nuocheng Major Business
7.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
7.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Guangzhou Nuocheng Recent Developments/Updates
7.2.6 Guangzhou Nuocheng Competitive Strengths & Weaknesses
7.3 Ningbo Rong'an
7.3.1 Ningbo Rong'an Details
7.3.2 Ningbo Rong'an Major Business
7.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
7.3.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Ningbo Rong'an Recent Developments/Updates
7.3.6 Ningbo Rong'an Competitive Strengths & Weaknesses
7.4 Hualan Bio-vaccine
7.4.1 Hualan Bio-vaccine Details
7.4.2 Hualan Bio-vaccine Major Business
7.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
7.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hualan Bio-vaccine Recent Developments/Updates
7.4.6 Hualan Bio-vaccine Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur SA
7.5.1 Sanofi Pasteur SA Details
7.5.2 Sanofi Pasteur SA Major Business
7.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
7.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur SA Recent Developments/Updates
7.5.6 Sanofi Pasteur SA Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
7.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Details
7.7.2 Bavarian Nordic Major Business
7.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
7.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bavarian Nordic Recent Developments/Updates
7.7.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.8 Serum Institute of India Pvt.
7.8.1 Serum Institute of India Pvt. Details
7.8.2 Serum Institute of India Pvt. Major Business
7.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
7.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Serum Institute of India Pvt. Recent Developments/Updates
7.8.6 Serum Institute of India Pvt. Competitive Strengths & Weaknesses
7.9 Chengdu Kanghua Biology
7.9.1 Chengdu Kanghua Biology Details
7.9.2 Chengdu Kanghua Biology Major Business
7.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
7.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Chengdu Kanghua Biology Recent Developments/Updates
7.9.6 Chengdu Kanghua Biology Competitive Strengths & Weaknesses
7.10 Changchun Zhuoyi Biology
7.10.1 Changchun Zhuoyi Biology Details
7.10.2 Changchun Zhuoyi Biology Major Business
7.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
7.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Changchun Zhuoyi Biology Recent Developments/Updates
7.10.6 Changchun Zhuoyi Biology Competitive Strengths & Weaknesses
7.11 Dalian Yali Peak
7.11.1 Dalian Yali Peak Details
7.11.2 Dalian Yali Peak Major Business
7.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
7.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Dalian Yali Peak Recent Developments/Updates
7.11.6 Dalian Yali Peak Competitive Strengths & Weaknesses
7.12 Jilin Huikang Biopharmaceutical Co., Ltd.
7.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Details
7.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
7.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
7.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Recent Developments/Updates
7.12.6 Jilin Huikang Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Rabies Vaccine (Vero Cell) Industry Chain
8.2 Human Rabies Vaccine (Vero Cell) Upstream Analysis
8.2.1 Human Rabies Vaccine (Vero Cell) Core Raw Materials
8.2.2 Main Manufacturers of Human Rabies Vaccine (Vero Cell) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Rabies Vaccine (Vero Cell) Production Mode
8.6 Human Rabies Vaccine (Vero Cell) Procurement Model
8.7 Human Rabies Vaccine (Vero Cell) Industry Sales Model and Sales Channels
8.7.1 Human Rabies Vaccine (Vero Cell) Sales Model
8.7.2 Human Rabies Vaccine (Vero Cell) Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2018-2023)
Table 5. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2024-2029)
Table 6. World Human Rabies Vaccine (Vero Cell) Production by Region (2018-2023) & (K Units)
Table 7. World Human Rabies Vaccine (Vero Cell) Production by Region (2024-2029) & (K Units)
Table 8. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2018-2023)
Table 9. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2024-2029)
Table 10. World Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Rabies Vaccine (Vero Cell) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Rabies Vaccine (Vero Cell) Major Market Trends
Table 13. World Human Rabies Vaccine (Vero Cell) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Rabies Vaccine (Vero Cell) Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Rabies Vaccine (Vero Cell) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Rabies Vaccine (Vero Cell) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Rabies Vaccine (Vero Cell) Producers in 2022
Table 18. World Human Rabies Vaccine (Vero Cell) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Rabies Vaccine (Vero Cell) Producers in 2022
Table 20. World Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Rabies Vaccine (Vero Cell) Company Evaluation Quadrant
Table 22. World Human Rabies Vaccine (Vero Cell) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Rabies Vaccine (Vero Cell) Production Site of Key Manufacturer
Table 24. Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
Table 25. Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
Table 26. Human Rabies Vaccine (Vero Cell) Competitive Factors
Table 27. Human Rabies Vaccine (Vero Cell) New Entrant and Capacity Expansion Plans
Table 28. Human Rabies Vaccine (Vero Cell) Mergers & Acquisitions Activity
Table 29. United States VS China Human Rabies Vaccine (Vero Cell) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Rabies Vaccine (Vero Cell) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Rabies Vaccine (Vero Cell) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 37. China Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 42. Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 47. World Human Rabies Vaccine (Vero Cell) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Rabies Vaccine (Vero Cell) Production by Type (2018-2023) & (K Units)
Table 49. World Human Rabies Vaccine (Vero Cell) Production by Type (2024-2029) & (K Units)
Table 50. World Human Rabies Vaccine (Vero Cell) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Rabies Vaccine (Vero Cell) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Rabies Vaccine (Vero Cell) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Rabies Vaccine (Vero Cell) Production by Application (2018-2023) & (K Units)
Table 56. World Human Rabies Vaccine (Vero Cell) Production by Application (2024-2029) & (K Units)
Table 57. World Human Rabies Vaccine (Vero Cell) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Rabies Vaccine (Vero Cell) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 62. Liaoning Chengda Major Business
Table 63. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
Table 64. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Liaoning Chengda Recent Developments/Updates
Table 66. Liaoning Chengda Competitive Strengths & Weaknesses
Table 67. Guangzhou Nuocheng Basic Information, Manufacturing Base and Competitors
Table 68. Guangzhou Nuocheng Major Business
Table 69. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
Table 70. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Guangzhou Nuocheng Recent Developments/Updates
Table 72. Guangzhou Nuocheng Competitive Strengths & Weaknesses
Table 73. Ningbo Rong'an Basic Information, Manufacturing Base and Competitors
Table 74. Ningbo Rong'an Major Business
Table 75. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
Table 76. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Ningbo Rong'an Recent Developments/Updates
Table 78. Ningbo Rong'an Competitive Strengths & Weaknesses
Table 79. Hualan Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 80. Hualan Bio-vaccine Major Business
Table 81. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
Table 82. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hualan Bio-vaccine Recent Developments/Updates
Table 84. Hualan Bio-vaccine Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur SA Major Business
Table 87. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
Table 88. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur SA Recent Developments/Updates
Table 90. Sanofi Pasteur SA Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
Table 94. Bharat Biotech Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 98. Bavarian Nordic Major Business
Table 99. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
Table 100. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bavarian Nordic Recent Developments/Updates
Table 102. Bavarian Nordic Competitive Strengths & Weaknesses
Table 103. Serum Institute of India Pvt. Basic Information, Manufacturing Base and Competitors
Table 104. Serum Institute of India Pvt. Major Business
Table 105. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
Table 106. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Serum Institute of India Pvt. Recent Developments/Updates
Table 108. Serum Institute of India Pvt. Competitive Strengths & Weaknesses
Table 109. Chengdu Kanghua Biology Basic Information, Manufacturing Base and Competitors
Table 110. Chengdu Kanghua Biology Major Business
Table 111. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 112. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Chengdu Kanghua Biology Recent Developments/Updates
Table 114. Chengdu Kanghua Biology Competitive Strengths & Weaknesses
Table 115. Changchun Zhuoyi Biology Basic Information, Manufacturing Base and Competitors
Table 116. Changchun Zhuoyi Biology Major Business
Table 117. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 118. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Changchun Zhuoyi Biology Recent Developments/Updates
Table 120. Changchun Zhuoyi Biology Competitive Strengths & Weaknesses
Table 121. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
Table 122. Dalian Yali Peak Major Business
Table 123. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
Table 124. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Dalian Yali Peak Recent Developments/Updates
Table 126. Jilin Huikang Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 127. Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
Table 128. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
Table 129. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Human Rabies Vaccine (Vero Cell) Upstream (Raw Materials)
Table 131. Human Rabies Vaccine (Vero Cell) Typical Customers
Table 132. Human Rabies Vaccine (Vero Cell) Typical Distributors
Table 1. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Rabies Vaccine (Vero Cell) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2018-2023)
Table 5. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2024-2029)
Table 6. World Human Rabies Vaccine (Vero Cell) Production by Region (2018-2023) & (K Units)
Table 7. World Human Rabies Vaccine (Vero Cell) Production by Region (2024-2029) & (K Units)
Table 8. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2018-2023)
Table 9. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2024-2029)
Table 10. World Human Rabies Vaccine (Vero Cell) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Rabies Vaccine (Vero Cell) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Rabies Vaccine (Vero Cell) Major Market Trends
Table 13. World Human Rabies Vaccine (Vero Cell) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Rabies Vaccine (Vero Cell) Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Rabies Vaccine (Vero Cell) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Rabies Vaccine (Vero Cell) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Rabies Vaccine (Vero Cell) Producers in 2022
Table 18. World Human Rabies Vaccine (Vero Cell) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Rabies Vaccine (Vero Cell) Producers in 2022
Table 20. World Human Rabies Vaccine (Vero Cell) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Rabies Vaccine (Vero Cell) Company Evaluation Quadrant
Table 22. World Human Rabies Vaccine (Vero Cell) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Rabies Vaccine (Vero Cell) Production Site of Key Manufacturer
Table 24. Human Rabies Vaccine (Vero Cell) Market: Company Product Type Footprint
Table 25. Human Rabies Vaccine (Vero Cell) Market: Company Product Application Footprint
Table 26. Human Rabies Vaccine (Vero Cell) Competitive Factors
Table 27. Human Rabies Vaccine (Vero Cell) New Entrant and Capacity Expansion Plans
Table 28. Human Rabies Vaccine (Vero Cell) Mergers & Acquisitions Activity
Table 29. United States VS China Human Rabies Vaccine (Vero Cell) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Rabies Vaccine (Vero Cell) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Rabies Vaccine (Vero Cell) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 37. China Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 42. Rest of World Based Human Rabies Vaccine (Vero Cell) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share (2018-2023)
Table 47. World Human Rabies Vaccine (Vero Cell) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Rabies Vaccine (Vero Cell) Production by Type (2018-2023) & (K Units)
Table 49. World Human Rabies Vaccine (Vero Cell) Production by Type (2024-2029) & (K Units)
Table 50. World Human Rabies Vaccine (Vero Cell) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Rabies Vaccine (Vero Cell) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Rabies Vaccine (Vero Cell) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Rabies Vaccine (Vero Cell) Production by Application (2018-2023) & (K Units)
Table 56. World Human Rabies Vaccine (Vero Cell) Production by Application (2024-2029) & (K Units)
Table 57. World Human Rabies Vaccine (Vero Cell) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Rabies Vaccine (Vero Cell) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 62. Liaoning Chengda Major Business
Table 63. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Product and Services
Table 64. Liaoning Chengda Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Liaoning Chengda Recent Developments/Updates
Table 66. Liaoning Chengda Competitive Strengths & Weaknesses
Table 67. Guangzhou Nuocheng Basic Information, Manufacturing Base and Competitors
Table 68. Guangzhou Nuocheng Major Business
Table 69. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Product and Services
Table 70. Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Guangzhou Nuocheng Recent Developments/Updates
Table 72. Guangzhou Nuocheng Competitive Strengths & Weaknesses
Table 73. Ningbo Rong'an Basic Information, Manufacturing Base and Competitors
Table 74. Ningbo Rong'an Major Business
Table 75. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Product and Services
Table 76. Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Ningbo Rong'an Recent Developments/Updates
Table 78. Ningbo Rong'an Competitive Strengths & Weaknesses
Table 79. Hualan Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 80. Hualan Bio-vaccine Major Business
Table 81. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Product and Services
Table 82. Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hualan Bio-vaccine Recent Developments/Updates
Table 84. Hualan Bio-vaccine Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur SA Major Business
Table 87. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Product and Services
Table 88. Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur SA Recent Developments/Updates
Table 90. Sanofi Pasteur SA Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Human Rabies Vaccine (Vero Cell) Product and Services
Table 94. Bharat Biotech Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 98. Bavarian Nordic Major Business
Table 99. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Product and Services
Table 100. Bavarian Nordic Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bavarian Nordic Recent Developments/Updates
Table 102. Bavarian Nordic Competitive Strengths & Weaknesses
Table 103. Serum Institute of India Pvt. Basic Information, Manufacturing Base and Competitors
Table 104. Serum Institute of India Pvt. Major Business
Table 105. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Product and Services
Table 106. Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Serum Institute of India Pvt. Recent Developments/Updates
Table 108. Serum Institute of India Pvt. Competitive Strengths & Weaknesses
Table 109. Chengdu Kanghua Biology Basic Information, Manufacturing Base and Competitors
Table 110. Chengdu Kanghua Biology Major Business
Table 111. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 112. Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Chengdu Kanghua Biology Recent Developments/Updates
Table 114. Chengdu Kanghua Biology Competitive Strengths & Weaknesses
Table 115. Changchun Zhuoyi Biology Basic Information, Manufacturing Base and Competitors
Table 116. Changchun Zhuoyi Biology Major Business
Table 117. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Product and Services
Table 118. Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Changchun Zhuoyi Biology Recent Developments/Updates
Table 120. Changchun Zhuoyi Biology Competitive Strengths & Weaknesses
Table 121. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
Table 122. Dalian Yali Peak Major Business
Table 123. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Product and Services
Table 124. Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Dalian Yali Peak Recent Developments/Updates
Table 126. Jilin Huikang Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 127. Jilin Huikang Biopharmaceutical Co., Ltd. Major Business
Table 128. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Product and Services
Table 129. Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Human Rabies Vaccine (Vero Cell) Upstream (Raw Materials)
Table 131. Human Rabies Vaccine (Vero Cell) Typical Customers
Table 132. Human Rabies Vaccine (Vero Cell) Typical Distributors
LIST OF FIGURES
Figure 1. Human Rabies Vaccine (Vero Cell) Picture
Figure 2. World Human Rabies Vaccine (Vero Cell) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Rabies Vaccine (Vero Cell) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 5. World Human Rabies Vaccine (Vero Cell) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2018-2029)
Figure 7. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2018-2029)
Figure 8. North America Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 9. Europe Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 10. China Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 11. Japan Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 12. Human Rabies Vaccine (Vero Cell) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 15. World Human Rabies Vaccine (Vero Cell) Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 17. China Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 22. India Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Rabies Vaccine (Vero Cell) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Rabies Vaccine (Vero Cell) Markets in 2022
Figure 26. United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Rabies Vaccine (Vero Cell) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 30. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 32. World Human Rabies Vaccine (Vero Cell) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Type in 2022
Figure 34. 0.5ml
Figure 35. 1ml
Figure 36. World Human Rabies Vaccine (Vero Cell) Production Market Share by Type (2018-2029)
Figure 37. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Type (2018-2029)
Figure 38. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Rabies Vaccine (Vero Cell) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Human Rabies Vaccine (Vero Cell) Production Market Share by Application (2018-2029)
Figure 44. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Application (2018-2029)
Figure 45. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Human Rabies Vaccine (Vero Cell) Industry Chain
Figure 47. Human Rabies Vaccine (Vero Cell) Procurement Model
Figure 48. Human Rabies Vaccine (Vero Cell) Sales Model
Figure 49. Human Rabies Vaccine (Vero Cell) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Human Rabies Vaccine (Vero Cell) Picture
Figure 2. World Human Rabies Vaccine (Vero Cell) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Rabies Vaccine (Vero Cell) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 5. World Human Rabies Vaccine (Vero Cell) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Region (2018-2029)
Figure 7. World Human Rabies Vaccine (Vero Cell) Production Market Share by Region (2018-2029)
Figure 8. North America Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 9. Europe Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 10. China Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 11. Japan Human Rabies Vaccine (Vero Cell) Production (2018-2029) & (K Units)
Figure 12. Human Rabies Vaccine (Vero Cell) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 15. World Human Rabies Vaccine (Vero Cell) Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 17. China Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 22. India Human Rabies Vaccine (Vero Cell) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Rabies Vaccine (Vero Cell) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Rabies Vaccine (Vero Cell) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Rabies Vaccine (Vero Cell) Markets in 2022
Figure 26. United States VS China: Human Rabies Vaccine (Vero Cell) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Rabies Vaccine (Vero Cell) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Rabies Vaccine (Vero Cell) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 30. China Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Rabies Vaccine (Vero Cell) Production Market Share 2022
Figure 32. World Human Rabies Vaccine (Vero Cell) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Type in 2022
Figure 34. 0.5ml
Figure 35. 1ml
Figure 36. World Human Rabies Vaccine (Vero Cell) Production Market Share by Type (2018-2029)
Figure 37. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Type (2018-2029)
Figure 38. World Human Rabies Vaccine (Vero Cell) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Rabies Vaccine (Vero Cell) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Human Rabies Vaccine (Vero Cell) Production Market Share by Application (2018-2029)
Figure 44. World Human Rabies Vaccine (Vero Cell) Production Value Market Share by Application (2018-2029)
Figure 45. World Human Rabies Vaccine (Vero Cell) Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Human Rabies Vaccine (Vero Cell) Industry Chain
Figure 47. Human Rabies Vaccine (Vero Cell) Procurement Model
Figure 48. Human Rabies Vaccine (Vero Cell) Sales Model
Figure 49. Human Rabies Vaccine (Vero Cell) Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
